APA (7th ed.) Citation

Couturier, M., Thomas, X., Raffoux, E., Huguet, F., Berthon, C., Simand, C., . . . Chevallier, P. (2021). Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Leukemia & Lymphoma, 62(3), 620. https://doi.org/10.1080/10428194.2020.1844198

Chicago Style (17th ed.) Citation

Couturier, Marie-Anne, et al. "Blinatumomab + Ponatinib for Relapsed/refractory Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in Adults." Leukemia & Lymphoma 62, no. 3 (2021): 620. https://doi.org/10.1080/10428194.2020.1844198.

MLA (9th ed.) Citation

Couturier, Marie-Anne, et al. "Blinatumomab + Ponatinib for Relapsed/refractory Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in Adults." Leukemia & Lymphoma, vol. 62, no. 3, 2021, p. 620, https://doi.org/10.1080/10428194.2020.1844198.